Literature DB >> 30022427

Resting-state connectivity and spontaneous activity of ventromedial prefrontal cortex predict depressive symptomology and peripheral inflammation in HIV.

Roger C McIntosh1, Robert Paul2, Lishomwa C Ndhlovu3, Melissa Hidalgo4, Judith D Lobo4, Maegen Walker5, Cecilia M Shikuma6, Kalpana J Kallianpur3.   

Abstract

Depression and chronic inflammation are common in persons infected with the human immunodeficiency virus (HIV+). Although depression and response to inflammatory challenge are shown to reflect activity in common neural networks, little is known regarding sub-clinical presentation in persons chronically infected with HIV. The relationship of resting-state functional connectivity (rsFC) between the subgenual anterior cingulate cortex (sgACC) and bilateral amygdala to Beck Depression Inventory-1 (BDI) scores were compared within a group of 23 HIV+ and 23 HIV-negative comparison adults. An interaction was found wherein lower rsFC between the sgACC and both right and left amygdala was associated with higher BDI scores in HIV+ individuals. Total BDI scores and plasma levels of IL-6, IL-8, TNF-α, and IL-10 made available from 10 of the HIV+ patients were regressed upon an index of spontaneous whole-brain activity at rest; i.e., the amplitude of low-frequency fluctuations (ALFFs). Elevated levels of depression and IL-6 were associated with increased ALFF in a cluster of voxels on the medial portion of the ventral surface of the frontal lobe (Brodmann Area 11). Within this sample of HIV+ individuals lower rsFC of the sgACC with subcortical limbic regions predicts greater burden of depressive symptomology whereas elevated activity in the adjacent BA 11 may reflect sickness, indexed by elevated IL-6, and associated depressive behaviors.

Entities:  

Keywords:  Cytokines; Immunodeficiency; Perigenual cingulate; Seed-based connectivity, salience network

Mesh:

Year:  2018        PMID: 30022427      PMCID: PMC6202140          DOI: 10.1007/s13365-018-0658-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  64 in total

1.  Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: a resting-state fMRI study.

Authors:  Wen-bin Guo; Feng Liu; Zhi-min Xue; Xi-jia Xu; Ren-rong Wu; Chao-qiong Ma; Sarah C Wooderson; Chang-lian Tan; Xue-li Sun; Jin-dong Chen; Zhe-ning Liu; Chang-qing Xiao; Hua-fu Chen; Jing-ping Zhao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-28       Impact factor: 5.067

2.  High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults.

Authors:  Uraina S Clark; Lawrence H Sweet; Susan Morgello; Noah S Philip; Ronald A Cohen
Journal:  Brain Imaging Behav       Date:  2017-06       Impact factor: 3.978

3.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

Review 4.  Searching for a baseline: functional imaging and the resting human brain.

Authors:  D A Gusnard; M E Raichle; M E Raichle
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

5.  Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men.

Authors:  Karen J Towgood; Mervi Pitkanen; Ranjababu Kulasegaram; Alex Fradera; Suneeta Soni; Naomi Sibtain; Laurence J Reed; Caroline Bradbeer; Gareth J Barker; Joel T Dunn; Fernando Zelaya; Michael D Kopelman
Journal:  Hum Brain Mapp       Date:  2012-04-12       Impact factor: 5.038

6.  Resting-state brain activity in major depressive disorder patients and their siblings.

Authors:  Chun-Hong Liu; Xin Ma; Xia Wu; Ting-Ting Fan; Yu Zhang; Fu-Chun Zhou; Li-Jun Li; Feng Li; Chang-Le Tie; Su-Fang Li; Dan Zhang; Zhen Zhou; Jie Dong; Yong-Jun Wang; Li Yao; Chuan-Yue Wang
Journal:  J Affect Disord       Date:  2013-03-07       Impact factor: 4.839

7.  Psychopathology and coping in recently diagnosed HIV/AIDS patients--the role of gender.

Authors:  Benjamin O Olley; Faniswa Gxamza; Soraya Seedat; Hugo Theron; Jantjie Taljaard; Emile Reid; Helmuth Reuter; Dan J Stein
Journal:  S Afr Med J       Date:  2003-12

8.  Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.

Authors:  Ashley M Behrman-Lay; Robert H Paul; Jodi Heaps-Woodruff; Laurie M Baker; Christina Usher; Beau M Ances
Journal:  J Neurovirol       Date:  2015-08-26       Impact factor: 2.643

Review 9.  HIV and depression: 2008 review and update.

Authors:  Judith G Rabkin
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

10.  Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.

Authors:  Marloes A M Janssen; Olga Meulenbroek; Stefan C A Steens; Bozena Góraj; Marjolein Bosch; Peter P Koopmans; Roy P C Kessels
Journal:  AIDS       Date:  2015-10-23       Impact factor: 4.177

View more
  9 in total

1.  Resting-state neural signatures of depressive symptoms in acute HIV.

Authors:  Carissa L Philippi; Leah Reyna; Laura Nedderman; Phillip Chan; Vishal Samboju; Kevin Chang; Nittaya Phanuphak; Nisakorn Ratnaratorn; Joanna Hellmuth; Khunthalee Benjapornpong; Netsiri Dumrongpisutikul; Mantana Pothisri; Merlin L Robb; Jintanat Ananworanich; Serena Spudich; Victor Valcour; Robert Paul
Journal:  J Neurovirol       Date:  2020-01-27       Impact factor: 2.643

2.  Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure.

Authors:  Sara R Nass; Michael Ohene-Nyako; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Front Neurosci       Date:  2022-05-04       Impact factor: 5.152

Review 3.  Mini-review: Elucidating the psychological, physical, and sex-based interactions between HIV infection and stress.

Authors:  Hannah Stadtler; Gladys Shaw; Gretchen N Neigh
Journal:  Neurosci Lett       Date:  2021-02-01       Impact factor: 3.197

4.  A double-hit of stress and low-grade inflammation on functional brain network mediates posttraumatic stress symptoms.

Authors:  Jungyoon Kim; Sujung Yoon; Suji Lee; Haejin Hong; Eunji Ha; Yoonji Joo; Eun Hee Lee; In Kyoon Lyoo
Journal:  Nat Commun       Date:  2020-04-20       Impact factor: 14.919

5.  Impact of Cannabis Use on Brain Structure and Function in Suppressed HIV Infection.

Authors:  Kalpana J Kallianpur; Rasmus Birn; Lishomwa C Ndhlovu; Scott A Souza; Brooks Mitchell; Robert Paul; Dominic C Chow; Lindsay Kohorn; Cecilia M Shikuma
Journal:  J Behav Brain Sci       Date:  2020-08-21

Review 6.  Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV.

Authors:  Jacqueline Hoare; Tatum Sevenoaks; Bulelwa Mtukushe; Taryn Williams; Sarah Heany; Nicole Phillips
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-18       Impact factor: 5.071

7.  Depression is associated with hippocampal volume loss in adults with HIV.

Authors:  Margarita Bronshteyn; Fan Nils Yang; Kyle F Shattuck; Matthew Dawson; Princy Kumar; David J Moore; Ronald J Ellis; Xiong Jiang
Journal:  Hum Brain Mapp       Date:  2021-06-05       Impact factor: 5.038

8.  Mild inflammation causes a reduction in resting-state amplitude of low-frequency fluctuation in healthy adult males.

Authors:  Kristian Stefanov; John McLean; Becky Allan; Jonathan Cavanagh; Rajeev Krishnadas
Journal:  Brain Neurosci Adv       Date:  2020-08-19

9.  Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV.

Authors:  Ronald J Ellis; Scott L Letendre; J Hampton Atkinson; David Clifford; Ann C Collier; Benjamin B Gelman; Christina Marra; J Allen McCutchan; Susan Morgello; Ned Sacktor; Bin Tang; Robert K Heaton
Journal:  Brain Behav Immun Health       Date:  2020-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.